Gauss Surgical’s Triton Fluid Management System, which provides real time estimation of surgical blood loss, has received FDA approval.
Triton enables physicians to accurately estimate intra-operative blood loss through the use of an iPad app.
Current methods of estimating blood loss have been criticized as being inaccurate.
“Blood loss in surgery has always been estimated and in situations of large blood loss, erroneous,” says Aryeh Shander, M.D., FCCM, FCCP, Chief, Department of Anesthesiology, Critical Care Medicine, Hyperbaric Medicine and Pain Management, Englewood Hospital and Medical Center, Englewood, NJ. “Over or under estimation of blood loss may lead to wrong clinical decisions. This new technology avails us the ability to more accurately account for blood loss with the potential to not only improve patient outcomes but also conserve healthcare resources.”
To use the app, the physician or nurse holds up an unfurled wet sponge in front of an iPad camera and presses a pedal in order to take a photo. The app then sends the image in a HIPAA compliant manner to a cloud server for image processing. The server then sends back an estimate of the blood in the wet sponge.
“We identified a critical unmet need for a fast and accurate way to estimate blood loss on sponges in the operating room,” said Siddarth Satish, Gauss Founder and Chief Technology Officer. “By leveraging the power of mobile devices in combination with our proprietary software we’re fulfilling that need with the potential to reduce unnecessary transfusions and the associated costs and complications.”
Gauss was a participant in the StartX Stanford University incubator. The company recently closed a $6.2million Series A round of funding.
Source: Gauss Surgical
